Citation tools
"Combining 18F-FDG PET/CT–Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer." Journal of Nuclear Medicine
60.10
(2019):
1366-1372.
Web. 29 April. 2025.